What is DMPHF's gross margin?

Dermapharm (DMPHF) has a gross margin of 33% and a net margin of 8%.

What is DMPHF's P/E ratio?

DMPHF's P/E ratio is 13.5 with ROE of 26%.

Where can I see DMPHF's full financials?

See Dermapharm (DMPHF) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Dermapharm (DMPHF) Financials — Revenue, Earnings, Cash Flow

Also trades as: DMP.DE (XETRA) · $vol 1M · 52D0.F (FSX) · $vol 0M

$47.69

+0.00 (+0.00%)

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 44 · $2.4B mcap · 11M float · 0.0000% daily turnover · Short 100% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$1B

Revenue

+0.5% YoY

$147M

Net Income

+36.9% YoY

$192M

Free Cash Flow

+9.3% YoY

33.4%

Gross Margin

24.9%

Op. Margin

8.1%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE25.6%

ROA6.7%

ROIC13.0%

Valuation

P/E13.5

P/B3.5

EV/EBITDA0.0

Leverage

Debt/Equity2.18

Current Ratio1.71

Interest Cov.5.1x

Quality Scores

Piotroski F5/9

Altman Z—

Beneish M-1.98